Search Results 761-770 of 16363 for monoclonal antibody

1. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

   0) hypersensitivity reactions to monoclonal antibodies, or history of anaphylaxis. Vaccination within 28 days of the first dose of study drugs and while on ...

2. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

   ... monoclonal antibodies): 2 weeks; Immune-checkpoint inhibitors (i.e., anti-PD-1, anti-PD-L1, or anti-CTLA-4): 4 weeks; Other monoclonal antibodies, antibody ...

3. Low blood cell counts: Side effects of cancer treatment - Mayo Clinic

   Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI · Muscle pain · Needle biopsy · Night sweats · No ...

4. Publications - Pedro Horna, M.D. - Mayo Clinic

   Single Antibody Detection of T-Cell Receptor alphabeta Clonality by Flow ... monoclonal and polyclonal antibodies. Am J Clin Pathol. 2011 Dec; 136 (6): ...

5. Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/​Round Cell Liposarcoma - Mayo Clinic

   ... monoclonal antibody therapy, checkpoint inhibitors,), Anti-cancer Vaccine, Gene therapy using an integrating vector (subjects who have received a gene ...

6. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

   Monoclonal antibody within 4 weeks. Not recovered from toxicity of any prior chemotherapy to grade ≤ 1. History of other active malignancies within 2 years ...

7. Evaluation of Laboratory Methods for Detecting Auto Antibodies to Complement Proteins - Mayo Clinic

   The goal of this study is to validate testing to be performed in the clinical immunology lab and have a source of positive patient sera. These tests include:.

8. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

   ... any disease. - Prior treatment with licensed or investigational CD33 targeting monoclonal antibody or antibody drug conjugate within 6 months of apheresis.

9. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

   Received monoclonal antibodies targeting cytokines (e.g., tumor necrosis factor (TNF) inhibitors, anti-IL-1 [e.g., anakinra, canakinumab], anti-IL-6 [e.g. ...

10. A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache - Mayo Clinic

    Current use or any prior exposure to any calcitonin-gene-related peptide (CGRP) antibody ... Known hypersensitivity to multiple drugs, monoclonal antibodies or ...